阿波利波蛋白E在密集沉积物中富含,是C3球病中密集沉积物疾病的标志物
Benjamin Madden1, Raman Deep Singh2, Mark Haas3
1Mayo Clinic Proteomics Core, Mayo Clinic, Rochester, Minnesota, USA.
Kidney international
|March 6, 2024
概括
密集沉积病 (DDD) 是一种C3球体病变 (C3G) 的形式,显示沉积物富含阿波利波蛋白E (ApoE). ApoE染色可能有助于诊断DDD,区分它与C3球球腺炎 (C3GN).
科学领域:
- 腎臟病學 (nephrology) 是一種醫學專業.
- 补充生物学的生物学.
- 病理学 病理学 病理学
背景情况:
- C3型血球膜炎 (C3G) 包括C3型血球膜炎 (C3GN) 和密集沉积病 (DDD).
- C3GN和DDD都表现出明亮的球体C3染色,但在电子显微镜的发现上有所不同.
- DDD显示密集的沉积物,而C3GN沉积物不是密集的,根本原因不明.
研究的目的:
- 研究DDD和C3GN之间的球沉积物中的分子差异.
- 确定潜在的生物标志物,以区分DDD和C3GN.
主要方法:
- 激光微解剖与质谱学 (LCM/MS) 结合,用于DDD,C3GN和对照病例的脏活检.
- 对阿波利波蛋白E (ApoE) 进行了免疫组织化学和共聚焦染色.
- 在较大的C3G病例队列上进行了验证研究.
主要成果:
- 与对照组相比,DDD和C3GN都显示补充蛋白增加.
- 与C3GN相比,DDD表现出明显更高的终端补充通路蛋白 (C5-9) 和阿波利波蛋白E (ApoE) 的水平.
- ApoE染色与DDD中的密集沉积有很强的相关性,使诊断区分成为可能.
结论:
- 在DDD中密集的沉积物以阿波利波蛋白E (ApoE) 的丰富为特征.
- ApoE染色作为电子显微镜的宝贵辅助,用于诊断DDD.
- ApoE检测为DDD提供了潜在的诊断工具,特别是当电子显微镜无法使用时.
更多相关视频
09:37Optimized Negative Staining: a High-throughput Protocol for Examining Small and Asymmetric Protein Structure by Electron Microscopy
Published on: August 15, 2014
43.6K
11:03Use of Capillary Electrophoresis Immunoassay to Search for Potential Biomarkers of Amyotrophic Lateral Sclerosis in Human Platelets
Published on: February 10, 2020
7.3K
相关概念视频
01:26Alzheimer's Disease: Overview
481
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
481
01:19Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers
91
Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
91